Treating Staphylococcus aureus colonization in patients prior to surgery is a common step to prevent surgical site infections, but patients do not always follow the multistep application instructions ...
As mentioned earlier, there is an urgent need for the development of novel antibiotics targeting S. aureus. Fortunately, a number of new agents active against MRSA and other Gram-positive pathogens ...
A new class of engineered proteins may counter infection caused by Staphylococcus aureus -- a bacterial species considered one of the largest global health threats, a new study suggests. A new class ...
PHILADELPHIA & SYDNEY--(BUSINESS WIRE)--Clinical stage synthetic cannabinoid company Botanix Pharmaceuticals Limited has today published positive data from a world first human clinical study, ...
A National Institutes of Health (NIH)-supported clinical trial has found that the outcome of treating complicated Staphylococcus aureus bloodstream infections with two intravenous (IV) doses of the ...
People who persistently carry Staphylococcus aureus (S. aureus) in their nose have fewer species of other bacteria, while ...
Chicago, Illinois, September 17, 2003 – Substantial treatment costs and illness are suffered by end-stage kidney (renal) disease (ESRD) patients who develop Staph aureus blood stream infections ...
THE purpose of this communication is to report an outbreak of staphylococcal infections on the Surgical Service of the Veterans Administration Hospital, Manchester, New Hampshire, the measures taken ...
Anaturopath and Managing Director, LamboDebs Nature Clinic, Lagos, Dr Lambo Adebisi, has said staphylococcus aureus can be cured with herbs made from ginseng and other preparations. According to him, ...
Despite challenges like high treatment costs and antibiotic resistance, strategic R&D investments and precision medicine innovations are shaping its futureDublin, Dec. 16, 2025 (GLOBE NEWSWIRE) -- The ...
British physician and microbiologist Alexander Fleming, discoverer of penicillin nearly 100 years ago, was the first to warn ...
YONKERS, N.Y., Oct. 26, 2020 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX) a clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback